Deepen your insight into the #pharma and #biopharma field! 💊 Are you passionate about the (bio)pharmaceutical industry? Do you want to stay up-to-date with the latest topics, trends, and technologies driving the industry forward? 🧪 Sign up for The Medicine Maker's newsletter today: https://bit.ly/3Vu15lw Join our community of industry professionals and enthusiasts now! #PharmaceuticalIndustry #Biotechnology
About us
The Medicine Maker celebrates the people, processes and vision that bring new drugs and biologics to market. The development and manufacture of new drugs and biological medicines draws on the talent, passion and experience of a wide range of professionals. The goal of The Medicine Maker is to bring this group into the limelight and, in doing so, to integrate the entire process, from the registration of an Investigational New Drug (IND) or Biologics License Application (BLA) through to the market launch of new therapies, and beyond.
- Website
-
http://themedicinemaker.com/
External link for The Medicine Maker
- Industry
- Internet Publishing
- Company size
- 11-50 employees
- Headquarters
- Knutsford, England
- Type
- Public Company
- Founded
- 2014
- Specialties
- pharmaceutical , biopharmaceutical, bioprocess, upstream, downstream, formulation, drug delivery, and dosage form
Locations
-
Primary
Chelford Road
Knutsford, England WA16 8, GB
-
Texere Publishing Inc. 175 Varick Street
New York, New York NY 10014, US
Updates
-
We recently had the opportunity to speak with Debra Weiss, Chief Operating Officer at the Bill & Melinda Gates Medical Research Institute about how she jumped from nursing to #pharma, why she joined #MRI, the importance of access to #medicine, good leadership, & more! #medicalresearch https://ow.ly/3jmx50SS8Ee
-
Why Does IBD Present So Many Clinical Research Challenges? Deepika Khedekar, Associate Centralized Clinical Trial Lead, IQVIA acknowledges the shortcomings in IBD-related clinical trials and reveals a potential holistic approach to overcoming them. 👉 https://bit.ly/3TZRylf
Charting the Future of IBD Trials
themedicinemaker.com
-
“Bikini Medicine” is the mistaken belief that women’s health only differs from men’s in the parts of the body that a bikini would cover. We need to acknowledge that #diseases can affect men and women differently. 💊🚺 https://bit.ly/3Q1dviK
Beyond ‘Bikini Medicine’
themedicinemaker.com
-
Gene therapy approvals have come thick and fast in 2023. Now let’s talk about how we can ramp up manufacturing speed with platform processes – featuring Catalent Pharma Solutions. 👉 https://bit.ly/42DgTpf
Getting Gene Therapy into the Fast Lane
themedicinemaker.com
-
How do we get medicines into space and, once there, how do we store and maintain them until they’re required? https://ow.ly/M1QC50SR85K
The Martian Pharmacy
themedicinemaker.com
-
Ascidian Therapeutics CEO Michael Ehlers aims to utilize #RNA exon editing to end #StargardtDisease. Read more here 👉 https://bit.ly/4cKsTcv
Enter Exon Editing
themedicinemaker.com
-
Andy Barrett, PhD, Chief Scientific Officer at Cessation Therapeutics, Inc., explains how – and why – we are tackling #opioid use disorder. Read more here: https://bit.ly/3wOeNqU.
-
💬 Mario Öeren, principal scientist at Optibrium, explains how #QuantumMechanics and #MachineLearning can be combined to develop new #drugs. 👉 https://bit.ly/4ao37tw
Sense and Sensitivity
themedicinemaker.com
-
Drew Hope, GMP Bio-manufacturing & Compliance Consultant and UK QP, eXmoor Pharma, suggests #automation at scale will be critical for unlocking #cellandgene therapies for patients. 👉 https://ow.ly/U4Bt50SPYlq